479 related articles for article (PubMed ID: 24711712)
1. Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods.
Ahmed R; Oborski MJ; Hwang M; Lieberman FS; Mountz JM
Cancer Manag Res; 2014; 6():149-70. PubMed ID: 24711712
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients.
Pirotte BJ; Levivier M; Goldman S; Massager N; Wikler D; Dewitte O; Bruneau M; Rorive S; David P; Brotchi J
Neurosurgery; 2009 Mar; 64(3):471-81; discussion 481. PubMed ID: 19240609
[TBL] [Abstract][Full Text] [Related]
3. Apparent diffusion coefficient in the evaluation of cerebral gliomas malignancy.
Ignjatović J; Stojanov D; Zivković V; Ljubisavljević S; Stojanović N; Stefanović I; Benedeto-Stojanović D; Ignjatović N; Petrović S; Aracki-Trenkić A; Radovanović Z; Lazović L
Vojnosanit Pregl; 2015 Oct; 72(10):870-5. PubMed ID: 26665552
[TBL] [Abstract][Full Text] [Related]
4. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
5. Clonal analysis of gliomas.
Kattar MM; Kupsky WJ; Shimoyama RK; Vo TD; Olson MW; Bargar GR; Sarkar FH
Hum Pathol; 1997 Oct; 28(10):1166-79. PubMed ID: 9343324
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
[TBL] [Abstract][Full Text] [Related]
7. Chromosome number and carmustine sensitivity in human gliomas.
Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
[TBL] [Abstract][Full Text] [Related]
8. Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.
Preul MC; Caramanos Z; Villemure JG; Shenouda G; LeBlanc R; Langleben A; Arnold DL
Neurosurgery; 2000 Feb; 46(2):306-18. PubMed ID: 10690719
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
Sipos L; Vitanovics D; Afra D
Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy of malignant gliomas: results from conventional treatment methods and the prospects of advanced techniques.
Rubino G; Sacco P; Cerase A; Volterrani L; Sebaste L; Pepi F; Pirtoli L
Radiol Med; 2004; 107(1-2):128-35. PubMed ID: 15031704
[TBL] [Abstract][Full Text] [Related]
13. [Histological classification of human gliomas: state of art and controversies].
Figarella-Branger D; Bouvier C
Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386
[TBL] [Abstract][Full Text] [Related]
14. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
Ohgaki H; Kleihues P
J Neuropathol Exp Neurol; 2005 Jun; 64(6):479-89. PubMed ID: 15977639
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.
Dhermain F
Chin J Cancer; 2014 Jan; 33(1):16-24. PubMed ID: 24384237
[TBL] [Abstract][Full Text] [Related]
16. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.
Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP
Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431
[TBL] [Abstract][Full Text] [Related]
17. Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study.
Chen W; Delaloye S; Silverman DH; Geist C; Czernin J; Sayre J; Satyamurthy N; Pope W; Lai A; Phelps ME; Cloughesy T
J Clin Oncol; 2007 Oct; 25(30):4714-21. PubMed ID: 17947718
[TBL] [Abstract][Full Text] [Related]
18. Input of molecular analysis in medical management of primary brain tumor patients.
Idbaih A; Duran-Peña A; Bonnet C; Ducray F
Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
[TBL] [Abstract][Full Text] [Related]
19. Redifferentiation therapy in brain tumors: long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term 1-alpha-hydroxycholecalciferol.
Trouillas P; Honnorat J; Bret P; Jouvet A; Gerard JP
J Neurooncol; 2001 Jan; 51(1):57-66. PubMed ID: 11349882
[TBL] [Abstract][Full Text] [Related]
20. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]